Xian Zheng
Department of Cardiovascular Surgery, Affiliated Cardiovascular Hospital of Shanxi Medical University,
Institute of Shanxi Cardiovascular Hospital, Taiyuan, 030024 Shanxi, China
Guanchang Cheng
Department of Cardiology, Huaihe Hospital of Henan University, Kaifeng, 475000 Henan, China
Jianwei Luo
Department of Cardiovascular Surgery, Affiliated Cardiovascular Hospital of Shanxi Medical University,
Institute of Shanxi Cardiovascular Hospital, Taiyuan, 030024 Shanxi, China
Qunhui Ye
Department of Cardiology, Huaihe Hospital of Henan University, Kaifeng, 475000 Henan, China
Yongzhi Deng
Department of Cardiovascular Surgery, Affiliated Cardiovascular Hospital of Shanxi Medical University,
Institute of Shanxi Cardiovascular Hospital, Taiyuan, 030024 Shanxi, China
Lin Wu
Department of Cardiology, Huaihe Hospital of Henan University, Kaifeng, 475000 Henan, China
PDF Fulltext XML References Citation
How to cite this article
Xian Zheng, Guanchang Cheng, Jianwei Luo, Qunhui Ye, Yongzhi Deng and Lin Wu, 2017. Odanacatib Inhibits Resistin-induced Cardiomyocyte Hypertrophy Through the Inactivation of ERK Signaling Pathway. International Journal of Pharmacology, 13: 212-217.
DOI: 10.3923/ijp.2017.212.217
URL: https://scialert.net/abstract/?doi=ijp.2017.212.217
DOI: 10.3923/ijp.2017.212.217
URL: https://scialert.net/abstract/?doi=ijp.2017.212.217